Subscribe
Gwendolyn Tawresey, Brittany Reeves, Emma Mann, and Gillian Schutt
3 October 2025NewsAmericasEmma Mann, Gwendolyn Tawresey, Brittany Reeves, and Gillian Schutt

ITC probes on the rise, but gender parity lags behind

A spike in agency investigations and more female lead counsel still leave a notable gender gap at the venue, find Troutman Pepper Locke’s Emma Mann, Gwendolyn Tawresey, Brittany Reeves, and Gillian Schutt.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
'Scrap the billable hour': LSIPR joins INTA panel on gender diversity
22 May 2025   A lively session explored findings from a report co-authored by LSIPR sister title WIPR, urging the IP sector to call time on outdated metrics that delay or derail women’s professional progress.
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025   As the US legal sector comes under political pressure for its inclusion efforts, LSIPR's sister magazine reveals its Top 100 for 2025, highlighting the individuals fighting to keep progress at the heart of IP.
Americas
‘Lift as you climb’: Abbott, BMS, Hitachi, LEGO Group counsels explore ‘empowerment’
6 March 2025   Senior legal voices from the world’s biggest companies share perspective on International Women’s Day theme | Action is key as gender parity remains a distant goal–forecasted to take at least 134 years.


Editor's picks

IP agencies vital to pharma and biotech grind to a halt
Americas
IP agencies vital to pharma and biotech grind to a halt
2 October 2025

Editor's picks

Americas
IP agencies vital to pharma and biotech grind to a halt
2 October 2025
Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025
Americas
Killing the golden goose of US drug innovation (Part I): Follow the money
10 September 2025
Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025
Americas
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
3 September 2025
Europe
Sandoz blocked by UK court from seeking Xarelto profits
2 September 2025

More features

Simmons & Simmons patent litigator jumps ship
IP agencies vital to pharma and biotech grind to a halt
USPTO trims workforce amid govt shutdown crisis
How impactful is the new USPTO director’s S101 decision?
Global vaccine patents rise, as data reveals shift in Big Pharma strategy
Philips wins unprecedented trade secret sanctions against Chinese defendants
Womble Bond Dickinson partners jump to rival firm
EPO ruling clarifies appeal rights, blocking third-party intervention